Report Eastern Europe - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Eastern Europe - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Eastern Europe: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Eastern Europe

The East European human and animal blood market fell to $X in 2021, dropping by -X% against the previous year. The total consumption indicated resilient growth from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption increased by +X% against 2015 indices. Over the period under review, the market hit record highs at $X in 2020, and then fell in the following year.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Eastern Europe

In value terms, human and animal blood production shrank to $X in 2021 estimated in export price. Overall, production, however, continues to indicate a remarkable increase. The pace of growth was the most pronounced in 2020 when the production volume increased by X% against the previous year. As a result, production reached the peak level of $X, and then shrank in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in Eastern Europe

In 2021, approx. X tons of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were exported in Eastern Europe; rising by X% against 2020 figures. Over the period under review, exports posted a prominent expansion. The most prominent rate of growth was recorded in 2017 when exports increased by X% against the previous year. Over the period under review, the exports reached the maximum in 2021 and are expected to retain growth in years to come.

In value terms, human and animal blood exports soared to $X in 2021. In general, exports saw a strong expansion. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

Exports by Country

The shipments of the five major exporters of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, namely Russia, Poland, the Czech Republic, Ukraine and Hungary, represented more than two-thirds of total export. It was distantly followed by Lithuania (X tons), constituting a X% share of total exports. Bulgaria (X tons) followed a long way behind the leaders.

From 2012 to 2021, the biggest increases were in Hungary (with a CAGR of +X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, Poland ($X), Hungary ($X) and the Czech Republic ($X) constituted the countries with the highest levels of exports in 2021, together comprising X% of total exports.

Hungary, with a CAGR of +X%, recorded the highest growth rate of the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in Eastern Europe stood at $X per ton in 2021, increasing by X% against the previous year. Overall, the export price, however, saw a relatively flat trend pattern. The level of export peaked at $X per ton in 2014; however, from 2015 to 2021, the export prices failed to regain momentum.

Prices varied noticeably by the country of origin: the country with the highest price was Hungary ($X per ton), while Ukraine ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Russia (+X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in Eastern Europe

In 2021, the amount of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses imported in Eastern Europe rose markedly to X tons, increasing by X% on 2020. Total imports indicated a prominent expansion from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2019 indices. The pace of growth was the most pronounced in 2016 when imports increased by X% against the previous year. The volume of import peaked at X tons in 2018; however, from 2019 to 2021, imports remained at a lower figure.

In value terms, human and animal blood imports reached $X in 2021. The total import value increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2013 when imports increased by X%. Over the period under review, imports hit record highs in 2021 and are likely to continue growth in years to come.

Imports by Country

Russia (X tons) and Poland (X tons) represented roughly X% of total imports in 2021. The Czech Republic (X tons) ranks next in terms of the total imports with a X% share, followed by Bulgaria (X%), Ukraine (X%), Hungary (X%), Slovakia (X%) and Belarus (X%). Romania (X tons) took a minor share of total imports.

From 2012 to 2021, the biggest increases were in Bulgaria (with a CAGR of +X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Russia ($X) constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Eastern Europe, comprising X% of total imports. The second position in the ranking was taken by Poland ($X), with a X% share of total imports. It was followed by the Czech Republic, with a X% share.

In Russia, human and animal blood imports declined by an average annual rate of -X% over the period from 2012-2021. The remaining importing countries recorded the following average annual rates of imports growth: Poland (+X% per year) and the Czech Republic (+X% per year).

Import Prices by Country

In 2021, the import price in Eastern Europe amounted to $X per ton, approximately equating the previous year. In general, the import price showed a noticeable slump. The most prominent rate of growth was recorded in 2017 an increase of X% against the previous year. Over the period under review, import prices attained the maximum at $X per ton in 2012; however, from 2013 to 2021, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was Belarus ($X per ton), while Bulgaria ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Belarus (+X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The country with the largest volume of human and animal blood consumption was Russia, accounting for 69% of total volume. Moreover, human and animal blood consumption in Russia exceeded the figures recorded by the second-largest consumer, Poland, fourfold. The Czech Republic ranked third in terms of total consumption with a 3.6% share.
The country with the largest volume of human and animal blood production was Russia, comprising approx. 77% of total volume. Moreover, human and animal blood production in Russia exceeded the figures recorded by the second-largest producer, Poland, fivefold. The Czech Republic ranked third in terms of total production with a 4.6% share.
In value terms, the largest human and animal blood supplying countries in Eastern Europe were Poland, Hungary and the Czech Republic, with a combined 75% share of total exports.
In value terms, Russia constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Eastern Europe, comprising 39% of total imports. The second position in the ranking was occupied by Poland, with a 16% share of total imports. It was followed by the Czech Republic, with a 12% share.
The export price in Eastern Europe stood at $56,716 per ton in 2021, dropping by -4.7% against the previous year.
In 2021, the import price in Eastern Europe amounted to $76,720 per ton, surging by 2% against the previous year.

This report provides an in-depth analysis of the market for human and animal blood in Eastern Europe. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)

Country coverage:

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Production in Eastern Europe, split by region and country
  • Trade (exports and imports) in Eastern Europe
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY
  8. 8. IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • Belarus
    • Bulgaria
    • Czech Republic
    • Estonia
    • Hungary
    • Latvia
    • Lithuania
    • Moldova
    • Poland
    • Romania
    • Russia
    • Slovakia
    • Ukraine
  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023
  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Free Data: Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses - Eastern Europe